143 related articles for article (PubMed ID: 29729827)
1. Association of miR-149 polymorphism with onset age and severity in Charcot-Marie-Tooth disease type 1A.
Nam SH; Kanwal S; Nam DE; Lee MH; Kang TH; Jung SC; Choi BO; Chung KW
Neuromuscul Disord; 2018 Jun; 28(6):502-507. PubMed ID: 29729827
[TBL] [Abstract][Full Text] [Related]
2. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
3. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
4. Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A.
Tao F; Beecham GW; Rebelo AP; Svaren J; Blanton SH; Moran JJ; Lopez-Anido C; Morrow JM; Abreu L; Rizzo D; Kirk CA; Wu X; Feely S; Verhamme C; Saporta MA; Herrmann DN; Day JW; Sumner CJ; Lloyd TE; Li J; Yum SW; Taroni F; Baas F; Choi BO; Pareyson D; Scherer SS; Reilly MM; Shy ME; Züchner S;
Ann Neurol; 2019 Mar; 85(3):316-330. PubMed ID: 30706531
[TBL] [Abstract][Full Text] [Related]
5. Severe phenotypes in a Charcot-Marie-Tooth 1A patient with PMP22 triplication.
Kim SM; Lee J; Yoon BR; Kim YJ; Choi BO; Chung KW
J Hum Genet; 2015 Feb; 60(2):103-6. PubMed ID: 25500726
[TBL] [Abstract][Full Text] [Related]
6. Modifier Gene Candidates in Charcot-Marie-Tooth Disease Type 1A: A Case-Only Genome-Wide Association Study.
Tao F; Beecham GW; Rebelo AP; Blanton SH; Moran JJ; Lopez-Anido C; Svaren J; Abreu L; Rizzo D; Kirk CA; Wu X; Feely S; Verhamme C; Saporta MA; Herrmann DN; Day JW; Sumner CJ; Lloyd TE; Li J; Yum SW; Taroni F; Baas F; Choi BO; Pareyson D; Scherer SS; Reilly MM; Shy ME; Züchner S;
J Neuromuscul Dis; 2019; 6(2):201-211. PubMed ID: 30958311
[TBL] [Abstract][Full Text] [Related]
7. The 5' regulatory sequence of the PMP22 in the patients with Charcot-Marie-Tooth disease.
Sinkiewicz-Darol E; Kabzińska D; Moszyńska I; Kochański A
Acta Biochim Pol; 2010; 57(3):373-7. PubMed ID: 20842290
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing practices for Charcot-Marie-Tooth type 1A disease.
Tousignant R; Trepanier A; Shy ME; Siskind CE
Muscle Nerve; 2014 Apr; 49(4):478-82. PubMed ID: 23963961
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1A.
Wang H; Davison M; Wang K; Xia TH; Call KM; Luo J; Wu X; Zuccarino R; Bacha A; Bai Y; Gutmann L; Feely SME; Grider T; Rossor AM; Reilly MM; Shy ME; Svaren J
Neurology; 2021 Aug; 97(5):e489-e500. PubMed ID: 34031204
[TBL] [Abstract][Full Text] [Related]
10. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
[TBL] [Abstract][Full Text] [Related]
11. Association of SNP in JPH1 gene with severity of disease in Charcot Marie Tooth 2K patients.
Kanwal S; Perveen S
J Pak Med Assoc; 2019 Feb; 69(2):241-243. PubMed ID: 30804591
[TBL] [Abstract][Full Text] [Related]
12. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
Roa BB; Garcia CA; Lupski JR
Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
[TBL] [Abstract][Full Text] [Related]
13. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and phenotypic spectrum of the most common causative genes of Charcot-Marie-Tooth disease in Hungarian patients.
Milley GM; Varga ET; Grosz Z; Nemes C; Arányi Z; Boczán J; Diószeghy P; Molnár MJ; Gál A
Neuromuscul Disord; 2018 Jan; 28(1):38-43. PubMed ID: 29174527
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of Charcot-Marie-Tooth disease type 1A: gene dosage as a novel mechanism for a common autosomal dominant condition.
Roa BB; Lupski JR
Am J Med Sci; 1993 Sep; 306(3):177-84. PubMed ID: 8128981
[TBL] [Abstract][Full Text] [Related]
16. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
17. Charcot-Marie-Tooth disease type 1A: a family study with microsatellites.
Qu Y; Carpenter NJ; Whetsell L; Smith SP; Say B
J Okla State Med Assoc; 1996 Nov; 89(11):395-9. PubMed ID: 8972170
[TBL] [Abstract][Full Text] [Related]
18. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
Kulkarni SD; Sayed R; Garg M; Patil VA
Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
Hanemann CO; Müller HW
Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
[TBL] [Abstract][Full Text] [Related]
20. Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A.
Ursino G; Alberti MA; Grandis M; Reni L; Pareyson D; Bellone E; Gemelli C; Sabatelli M; Pisciotta C; Luigetti M; Santoro L; Massollo L; Schenone A
Neuromuscul Disord; 2013 Nov; 23(11):902-6. PubMed ID: 23891256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
